The agency has published a list of 24 high-risk infectious diseases as a reference tool for funders and researchers.
The future of healthcare is not just new drugs; it is about smarter, more responsive solutions that prioritise patients ...
The future of pharmaceutical investment lies in the convergence of ESG principles with a strong emphasis on positive social ...
The pharmacy benefit landscape is shifting. With rising costs, limited transparency, and rigid structures imposed by legacy pharmacy benefit managers (PBMs), organizations are considering a bold ...
Artificial Intelligence is revolutionizing pharmaceuticals, accelerating drug discovery, and optimizing clinical trials. Yet, ...
In the fourth part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life ...
Few understand these challenges better than Paul Kusserow ’85. As the Chairman of the Board and former CEO of Amedisys, a ...
Powered by Real-World Expertise: Cliniphai has built deep operational experience across clinical studies and is working with trusted partners that have spent decades ensuring linguistic accuracy in ...
The pharmaceutical industry on Thursday blasted the UK government's levy that aims to curb the national health system's drugs ...
Somehow Washington regards the industry, which has saved and improved tens of millions of lives, as a villain.
Now set to become an annual event, we look forward to continuing our role in shaping the future ... of pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results